Skip to main content
SpringerLink
Log in

Finding cost-effective therapies in early aggressive RA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Treatment of Early Aggressive RA

Reference

  • Michaud K, et al. Cost-Effectiveness Analysis Of Triple Therapy Versus Etanercept Plus Methotrexate In Early Aggressive Rheumatoid Arthritis: Analysis Based On The TEAR Trial. 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals : abstr. 2646, 25 Oct 2013.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Finding cost-effective therapies in early aggressive RA. PharmacoEcon Outcomes News 692, 13 (2013). https://doi.org/10.1007/s40274-013-0910-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0910-8

Search

Navigation